Literature DB >> 23395608

Tumor suppressor protein VHL inhibits Hedgehog-Gli activation through suppression of Gli1 nuclear localization.

Hyun Kook Cho1, So Young Kim, Kook Hwan Kim, Hyeong Hoe Kim, JaeHun Cheong.   

Abstract

The transcription factor Gli1 acts in the last known step of the Hedgehog signaling, and deregulation of Gli1 is implicated in human cancers. VHL protein is widely expressed in both fetal and adult tissues and acts as a tumor suppressor. Here, we demonstrate the molecular mechanism through which VHL inhibits the Hedgehog-Gli pathway. VHL decreased Gli1-mediated promoter transactivation as well as the expression of Hedgehog/Gli pathway target genes. Nuclear translocation of cytosolic Gli1 protein was inhibited by VHL via protein-protein interaction. These results indicate that overexpression of VHL may antagonize Hedgehog-Gli activation at the post-translational level in Hedgehog pathway-induced cancers.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23395608     DOI: 10.1016/j.febslet.2013.01.050

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

Review 1.  Transcriptional regulation of graded Hedgehog signaling.

Authors:  Kristin N Falkenstein; Steven A Vokes
Journal:  Semin Cell Dev Biol       Date:  2014-05-23       Impact factor: 7.727

2.  Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.

Authors:  Tshering D Lama-Sherpa; Shamik Das; Dominique C Hinshaw; Sarah C Kammerud; Patrick N Song; Heba A Alsheikh; Anna G Sorace; Rajeev S Samant; Lalita A Shevde
Journal:  Mol Cancer Res       Date:  2021-09-30       Impact factor: 6.333

3.  The long form of pVHL is artifactually modified by serine protease inhibitor AEBSF.

Authors:  Daniel Tarade; Shelley He; Jonathan St-Germain; Avi Petroff; Anya Murphy; Brian Raught; Michael Ohh
Journal:  Protein Sci       Date:  2020-06-25       Impact factor: 6.725

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.